Tag: CanPath

Attention Students and Trainees: CanPath Access Office Hours

Posted on by pathwp

Are you a student seeking data for your upcoming project? Wondering how to navigate the CanPath access process effectively? Join CanPath Access Office Hours to discover the requirements for successful student-led projects, learn the ins and outs of data access, and get hands-on guidance from our Access Office experts to elevate your research game. This virtual series provides researchers with an opportunity every quarter to ask questions they may have about CanPath data and biosamples, the access process or the CanPath Portal. Members of the Access Office will be available to answer questions and demonstrate how to navigate the Portal and online application. Register: https://us02web.zoom.us/meeting/register/tZUpduiupzwuHNPy42P8q1QiG-JiUNDq211N#/registration

Dr. John Lewis at #CCRC2023

Posted on by pathwp

Dr. John Lewis is a Professor in the Department of Oncology at the University of Alberta and the Bird Dogs Chair in Translational Oncology. Dr. Lewis’ research interests include translational prostate cancer research, and the Lewis Lab utilizes real-time intravital imaging of the tumour microenvironment to learn about the critical steps of cancer progression, including the growth of new blood vessels and the gain of tumour cell motility that leads to metastasis. Using CanPath data, Dr. Lewis created predictive models for diseases using a standardized data analysis platform. These models offer insights into the factors that increase the risk of developing a particular disease. The platform, which has demonstrated superior accuracy in predicting prostate cancer compared to existing models, can now be applied efficiently to predict a range of diseases like cancer, heart conditions, lung diseases, diabetes, and neurological disorders using CanPath questionnaire data. Learn more about how the Lewis Lab uses CanPath data: https://canpath.ca/2022/10/webinar-november-2022/. Dr. Lewis will be presenting at the conference plenary on AI Across the Research Spectrum on Sunday, November 12, at 4:10 pm AST. Dr. Lewis will be speaking on the development and commercialization of machine learning models to predict disease.

Dr. Trevor Dummer and Mohadeseh Ahmadi at #CCRC2023

Posted on by pathwp

Dr. Trevor Dummer will be attending the Canadian Cancer Research Conference. Dr. Dummer is the co-Scientific Director for CanPath, an Associate Professor at the School of Population and Public Health at the University of British Columbia, the Canadian Cancer Society Chair in Primary Prevention, and Affiliated Scientist, BC Cancer. Dr. Dummer’s research interests include how the environment, communities and neighbourhoods influence health outcomes, including cancer.  Dr. Dummer will be in attendance at the Canadian Cancer Research Conference along with his student, Mohadeseh Ahmadi. Mohadeseh is a MSc student in the School of Population and Public Health at the University of British Columbia. They will be presenting on the association between traffic-related air pollution and breast cancer risk in post-menopausal women in Alberta’s Tomorrow Project in a lightning session on Tuesday, November 14th at 10:40am AST.    

Dr. Jennifer Vena and Dr. Rachel Murphy at #CCRC2023

Posted on by pathwp

Dr. Jennifer Vena and Dr. Rachel Murphy will be attending the Canadian Cancer Research Conference from Alberta and British Columbia. Dr. Vena is the Scientific Director of Alberta’s Tomorrow Project and a Research Scientist at CancerControl Alberta with Alberta Health Services. Dr. Vena’s research interests focus on lifestyle behaviours and prevention of cancer and chronic diseases, as well as population cohort science, and involves scientific, strategic, and operational elements. Dr. Vena will be presenting a poster on the dietary screener that was developed to assess adherence to Canada’s Food Guide and how it could be used for cancer prevention research. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST.  Dr. Murphy is a Senior Scientist at BC Cancer and an Associate Professor at the School of Population and Public Health at the University of British Columbia. Dr. Murphy’s research interests include reducing the risk of cancer through modifiable lifestyle factors, with a focus on healthy eating and body weight. Additional interests include older adults and other populations with increased risk of cancer, knowledge translation of nutrition evidence, and metabolomics; the study of small molecules in biological systems that may provide insight on pathways linking lifestyle factors and disease.   Dr. Murphy will be presenting at and chairing a session with Patient Partner, Rachelle Bould on Reducing Your Risk of Cancer on Tuesday, November 14th at 9:00am AST. The presenters include:  Dr. Rachel Murphy (University of British Columbia, BC Cancer) speaking about diet, geographies and risk for cancer  Dr. Laura Struik (University of British Columbia) speaking about factors influencing youth vaping uptake  Dr. Paul Demers (Occupational Cancer Research Centre, Ontario Health) speaking about the etiology of rare cancers in a large occupational cohort  Umaima Abbas (University of Western Ontario) speaking about the effectiveness and cost-effectiveness of population level policies to reduce alcohol use   

CanPath at #CCRC2023: Canada’s Largest Population Laboratory for Cancer Research

Posted on by pathwp

Dr. Philip Awadalla, Scientific Director of CanPath, and Patient Partner/Atlantic PATH participant, Pauline McIntyre, will chair a panel at the Canadian Cancer Research Conference, “CanPath: Canada’s Largest Population Laboratory for Cancer Research” on Monday, November 13th at 11:40 AST. Presenters include Dr. Dylan O’Sullivan, Dr. Samina Abidi, Dr. Sara Nejatinamini, and Dr. Vikki Ho. Dr. Dylan O’Sullivan is a Research Scientist at Alberta Health Services and an Adjunct Assistant Professor in the Cumming School of Medicine, Department of Community Health Sciences at the University of Calgary. His research interests include reducing the cancer burden across the full cancer control continuum (prevention, screening, and outcomes) with the use of existing methods and the development of novel data analytics. Dr. O’Sullivan will be presenting on the risk factors for early-onset colorectal cancer using CanPath data. Dr. Samina Abidi is an Associate Professor in the Department of Community Health and Epidemiology at the Faculty of Medicine at Dalhousie University and is cross appointed in the Faculty of Computer Science. Dr. Abidi has a unique skill set where she is a clinician with an expertise in health informatics. Her research interests include health knowledge integration, modelling and computerization, patient-centred care, chronic disease self-management and behaviour modification, clinical guidelines based clinical decision support and care planning, ambient assistant living, data visualizations, health IT evaluation. Dr. Abidi will be presenting on a digital health and artificial based public health platform for cancer risk prediction using data from Atlantic PATH.   Dr. Sara Nejatinamini is a Research Associate at Alberta’s Tomorrow Project. She received her PhD degree in Nutrition and Metabolism from the University of Alberta. Prior to joining the ATP, she undertook postdoctoral training at the University of Calgary with a focus on health inequities. Dr. Nejatinamini’s research interests include public health, nutrition and cancer. Her research focuses on the role of modifiable lifestyle factors on cancer and other chronic disease risk. She applies epidemiological and implementation science methods and principles in her research to identify factors to prevent cancer and other chronic diseases and inform health interventions. Dr. Nejatinamini will be presenting on changes in breast and cervical cancer screening during the COVID-19 pandemic using data from Alberta’s Tomorrow Project.  Dr. Vikki Ho is the co-Scientific Director of CARTaGENE and holds the Chair in Sex and Gender Sciences in Cancer Research from the Canadian Institutes of Health Research. She is an Assistant Professor in the Department of Social and Preventive Medicine in the School of Public Health (ESPUM) at the University of Montreal and a Researcher at the affiliated Hospital Research Centre (CRCHUM). Dr. Ho’s research interests focus on the intersection of environmental, lifestyle, occupational, and individual susceptibility factors in cancer etiology. Dr. Ho will be presenting on CARTaGENE’s research platform and the wide array of data sources for cancer prevention research, including environmental factors and biomarkers. She will specifically focus on occupational exposures and lung cancer biomarkers, and occupational exposures to endocrine disrupting chemicals and colorectal cancer risk. Dr. Ho will also present a poster on the CARTaGENE cohort. Posters will be up for the duration of the conference and during viewing sessions on Sunday, November 12th from 12-1:30pm AST and Monday, November 13th from 1:10-2:40pm AST. 

Dr. Robin Urquhart at #CCRC2023

Posted on by pathwp

Dr. Robin Urquhart is the co-chair of the Scientific Program Committee at the Canadian Cancer Research Conference. She is also the Scientific Director of Atlantic PATH; Canadian Cancer Society (Nova Scotia Division) Endowed Chair in Population Cancer Research; Associate Professor, Department of Community Health and Epidemiology, Dalhousie University; Senior Scientist, Beatrice Hunter Cancer Research Institute; and Affiliate Scientist, Nova Scotia Health. Dr. Urquhart’s research interests include access to and quality of cancer care, patient and family outcomes and experiences, and how to more effectively move research evidence into clinical practice and healthcare policy.   During the conference, Dr. Urquhart can be found:  At the Opening Remarks (Sunday, November 12th, 9am AST)  Chairing a session on the Crises Affecting Healthcare (Monday, November 13th at 11:40am AST)  At the Patient Engagement Workshop (Monday, November 13th at 4:40pm AST)  Chairing a session on environment and cancer with Patient Partner, Dr. Don Desserud (Tuesday, November 14th at 11:40am AST).   

Dr. Philip Awadalla represents CanPath at #CCRC2023

Posted on by pathwp

CanPath Scientific Director, Dr. Philip Awadalla, will represent CanPath at the Canadian Cancer Research Conference. Dr. Awadalla is also the Director of Computational Biology and Senior Investigator at the Ontario Institute for Cancer Research, Professor of Population and Medical Genomics at the University of Toronto, and Executive Director of the Ontario Health Study. His research interests include the development of genomics approaches, model-based tools, and population-based approaches to study mutation rates, genome biology, and cancer.   Along with Patient Partner and Atlantic PATH participant, Pauline McIntyre, Dr. Awadalla will chair a panel on CanPath: Canada’s Largest Population Laboratory for Cancer Research on Monday, November 13th at 11:40 AST. Presenters include    Dr. Dylan O’Sullivan (Alberta Health Services, University of Calgary) speaking about risk factors for early-onset colorectal cancer;  Dr. Samina Abidi (Dalhousie University) speaking about a digital health and artificial-based public health platform for cancer risk prediction;  Dr. Sara Nejatinamini (Alberta Tomorrow Project, Alberta Health Services) speaking about changes in breast and cervical cancer screening during the COVID-19 pandemic; and   Dr. Vikki Ho (University of Montreal, CARTaGENE) speaking about harnessing data to build a cancer prevention research program.  Dr. Awadalla will also represent CanPath on a panel chaired by Dr. Sherri Christian on Networked Cancer Research in Canada on Tuesday, November 14th at 9:00am AST.   

Canadian Cancer Research Conference Community Event

Posted on by pathwp

CanPath and Atlantic PATH are excited to participate in the upcoming Community Event, “Cancer: Prevention, Treatment & You” at the Canadian Cancer Research Conference. Our team members are looking forward to meeting you!   Megan Fleming, Communications and Knowledge Translation Officer, CanPath  Jason Hicks, Executive Director, Atlantic PATH   Ellen Sweeney, Research Director, Atlantic PATH  This free event is open to the public:  Explore an exhibit hall with resources for people of all ages  Speak one-on-one with patient advocates  Learn about risk reduction  Get up-to-date information on screening and treatment, as well as helpful advice on life after a cancer diagnosis   Panel: Moderated by Eilish Bonang, Anchor of Global Morning News in Halifax, you will hear about interesting research from:  Dr. Nathalie Saint-Jacques, MSc, PhD, Senior Epidemiologist, Nova Scotia Health Cancer Care Program  Dr Michael N. Ha, MD, PhD, FRCPC, Radiation Oncologist, Nova Scotia Health  Mr. Tom Christensen, MSc, Clinical Exercise Physiologist (CSEP-CEP), Physical Activity and Cancer (PAC) Lab   Details:   Saturday, November 11th   1:30-4:30pm AST  Halifax Convention Centre: Argyle Suite  1650 Argyle Street, Halifax 

CanPath and Regional Cohorts at the Canadian Cancer Research Conference (#CCRC2023)

Posted on by pathwp

CanPath and its regional cohorts will be well represented at the upcoming Canadian Cancer Research Conference in Halifax on November 11-14th. This conference is hosted by the Canadian Cancer Research Alliance. It brings together the Canadian cancer research community and spans the research spectrum.   We’re pleased to have attendees from the CanPath National Coordinating Centre and regional cohorts including Atlantic PATH, CARTaGENE (Quebec), the Ontario Health Study, the Manitoba Tomorrow Project, Alberta’s Tomorrow Project, and the BC Generations Project.   Over the next two weeks, we will share more details about where to find CanPath and regional cohort representatives at the conference (e.g., plenaries, concurrent and lightning sessions, poster presentations, etc.), as well as researchers who have used data and biological samples from CanPath and the regional cohorts. Stay tuned! 

World Mental Health Day

Posted on by pathwp

October 10th is World Mental Health Day and Atlantic PATH is pleased to be involved in multiple studies examining mental health and well-being. COVID Global Mental Health Consortium The COVID Global Mental Health Consortium was recently funded and includes 23 global cohorts representing 2.8 million participants. It will produce a global evaluation of pandemic-related mental health outcomes using individual-level harmonized longitudinal data. Research will begin this fall and we look forward to participating and contributing to this important work. Depression, Anxiety and Risk of Cancer Depression and anxiety have long been thought to be related to an increased cancer risk. The Psychosocial Factors and Cancer Incidence (PSY-CA) consortium is led from the Netherlands and includes Atlantic PATH, CARTaGENE (Quebec) and the Ontario Health Study. This study found that mental health was not related to an increased risk of cancer. Shift Work & Mental Health The relationship between mental health and shift work was evaluated among Atlantic PATH participants. Shift workers reported higher levels of each of the mental health domains compared to non-shift workers. Shift workers were more likely to have increased rates of depression and poor self-rated health, as well as depressive and anxiety symptom scores compared to non-shift workers. As a result, shift workers may be at increased risk of comorbidity, poor quality of life, missed work, and early retirement. Physical Activity and Self-Rated Health The population of Atlantic Canada is aging rapidly and has among the highest rates of chronic disease in the country. This study examined the association between physical activity and self-rated health among Atlantic PATH participants. The results suggest that physical activity is associated with and may help to improve perceived health status of individuals with one or more chronic conditions. The findings support literature suggesting that physical activity can be beneficial for adults as they age with chronic disease. Anxiety, Depression and Prostate Cancer Prostate cancer is the most prevalent form of cancer among males in Canada, and has one of the most favorable survival rates among all cancers. The incidence rates are expected to remain high with an aging population and an increase in asymptomatic detection. Prostate cancer survivors had higher odds of anxiety or depression symptoms compared to those with no history of cancer or a history of any other type of cancer. Prostate cancer survivors with a low household income had a higher rate of depression compared to those  with a history of another type of cancer and a high household income. Prostate cancer survivors who were treated with surgery had a higher odds of depression symptoms compared to those with a history of other types of cancer. Increased rates of anxiety and depression among males with a history of prostate cancer highlights the need for mental health screening among prostate cancer survivors. The findings highlight the importance of a multidisciplinary effort to prioritize and deliver comprehensive mental health support throughout the prostate cancer journey.